Condition
Cystostomy; Complications
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Unknown2
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03032822TerminatedPrimary
Opioid Consumption in Cystectomy Patients
NCT05822518Not ApplicableCompleted
Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy
NCT04539743Unknown
Modified Step by Step Mitrofanoff Continent Cystostomy : Functional Results of a Teachable Procedure
NCT04219046Phase 2Unknown
Evaluation of Naloxegol in the Prevention of POI After Cystectomy
Showing all 4 trials